bpc-157 and mots-c FDA panel backs compounded BPC-157, KPV peptides in win for RFK Jr Peptides are gaining attention—but not

They arrived yesterday

Phase I human trial of parent molecule (TB-4) showed no serious adverse events Mild injection site reactions possible Same theoretical angiogenesis/tumor concern as BPC-157 Head rush or lightheadedness reported anecdotally at higher doses Can You Stack BPC-157 and TB-500

They also represented a departure from FDA staff recommendations against inclusion, creating one of the most closely watched peptide developments in years

Be sure to look for our new labels with the MADE IN USA SHIELD

Muscle strains, ligament injuries, arthritis pain, and problems with movement can all be helped by it

Proper nasal technique proves absolutely critical - head tilted slightly forward (not back), gentle breathing (not hard sniffing), alternating nostrils with 1-2 minute intervals, and avoiding immediate swallowing determines success versus complete failure